Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
about
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisPlant-derived immunomodulators: an insight on their preclinical evaluation and clinical trialsCombinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infectionSubacute sclerosing panencephalitisA placebo-controlled trial of isoprinosine in patients with multiple sclerosisInosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.Discovery of immunopotentiatory drugs: current and future strategies.The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetesApplication of chemical immunomodulators to the treatment of cancer and AIDS.Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro.The safety profile of Polyoxidonium in daily practice: results from postauthorization safety study in Slovakia.Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis.Genotoxicity and Mutagenicity of Inosine Pranobex
P2860
Q24186663-ED45695D-E151-4C27-B87A-08A93E51E5A1Q26784434-BF8CB315-6107-4133-9C2C-97059D0A02B1Q28339702-FDAE87C6-9218-42FA-8149-C6D6BE7641BDQ28368043-C9703E33-211A-4192-9380-947AB9607946Q30670817-2C76902E-E90F-44A0-811C-DA8D946D31EFQ33731211-0A4BA2AE-C899-4D50-A69F-B3C450A7CF4CQ34520643-83C27C6E-D2E4-4859-80C4-05EA447E48C6Q35009482-3BBC09D8-633C-4C0C-A489-D92398B69EDEQ37160327-AC078075-E874-42C9-8F5B-8FB28C1FE761Q40651609-AD9DAA67-8ADA-46EA-B18E-5352BBFD442CQ40797649-512229D2-B786-4DAE-B20E-9749CF6B686CQ47278615-9A42059F-083C-41CD-B580-6A575396D544Q48603607-9E6581A0-C2AA-4A7F-92FB-BA4FCE8296F1Q58568209-9BE7E68F-AA71-4B4B-9522-CE65572DACBE
P2860
Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Inosine pranobex. A preliminar ...... ies, and therapeutic efficacy.
@en
type
label
Inosine pranobex. A preliminar ...... ies, and therapeutic efficacy.
@en
prefLabel
Inosine pranobex. A preliminar ...... ies, and therapeutic efficacy.
@en
P2093
P1433
P1476
Inosine pranobex. A preliminar ...... ies, and therapeutic efficacy.
@en
P2093
Campoli-Richards DM
P304
P356
10.2165/00003495-198632050-00001
P577
1986-11-01T00:00:00Z
P6179
1041048744